Chinese Journal of Lung Cancer (Apr 2020)

Progress in Role of FEZF1-AS1 in Non-small Cell Lung Cancer

  • Jin CHEN,
  • Rong YIN,
  • Xinyin LIU

DOI
https://doi.org/10.3779/j.issn.1009-3419.2020.101.05
Journal volume & issue
Vol. 23, no. 4
pp. 294 – 298

Abstract

Read online

Nowadays, accumulating evidence indicates that long non-coding RNA (lncRNA) play vital roles in tumorigenesis. As a newly discovered lncRNA, FEZ family zinc finger 1-antisense RNA 1 (FEZF1-AS1) is markedly upregulated in various malignant tumors including non-small cell lung cancer (NSCLC). Aberrant expression of FEZF1-AS1 is related to clinical characteristics of patients with NSCLC and suggests poor prognosis. Moreover, FEZF1-AS1 can regulate numerous biological processes, such as cell proliferation, migration and invasion through different mechanisms. In this article, we systematically summarize the recent research progress of FEZF1-AS1 in NSCLC, which might be a novel target for clinical therapy.

Keywords